𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer

✍ Scribed by Wade S. Samowitz; Roger K. Wolff; Khe Ni Ma; Kristen Andersen; Bette Caan; Martha L. Slattery

Book ID
113808798
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
98 KB
Volume
595
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of GSTT1, GSTM1, GSTP1 and NAT2 g
Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer
✍ Jean-Marc Ferraz; Franck ZinzindohouΓ©; Thierry Lecomte; Paul-Henri Cugnenc; Mari πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 92 KB

## Abstract Which carcinogens are of influence in the development of human colorectal cancers remains a question; one answer could be the finding that specific polymorphisms in xenobiotic metabolizing enzymes are related to particular mutations in cancer genes. __KRAS2__ and __TP53__ gene mutations

Genetic polymorphisms in cell cycle regu
Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer
✍ Xuemei Zhang; Xiaoping Miao; Yongli Guo; Wen Tan; Yifeng Zhou; Tong Sun; Yonggan πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 226 KB

The tumor suppressor TP53 pathway plays a crucial role in preventing carcinogenesis through its ability to impose cell cycle arrest and apoptosis following DNA damage and oncogene activation. MDM2 is a key negative regulator of the TP53 pathway and is overexpressed in many cancers as oncoprotein. We